trending Market Intelligence /marketintelligence/en/news-insights/trending/henm54xadxdnmll0wcurla2 content esgSubNav
In This List

Meridian Bioscience CFO to retire; replacement named

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Meridian Bioscience CFO to retire; replacement named

Meridian Bioscience Inc. said Melissa Lueke is retiring as executive vice president and CFO.

Lueke has been the company's CFO since January 2001. She agreed to provide consulting services to the company on matters related to financial reporting and accounting within an initial three-year period.

The company named Eric Rasmussen to the positions of executive vice president, CFO and principal financial officer. Rasmussen joined Meridian Bioscience as executive vice president of corporate development in June.

Meridian Bioscience also appointed Bryan Baldasare to the role of chief accounting officer. He was previously the company's senior vice president, corporate controller and treasurer.

All these management changes are effective Jan. 1, 2019.

Cincinnati-based Meridian Bioscience is a life science company that manufactures and sells diagnostic test kits, purified reagents and biopharmaceutical enabling technologies.